Fred Chereau has served as president and chief executive officer since April 2016. Prior to joining LogicBio, Fred served as the president and chief operating officer of aTyr Pharma Inc. from February 2014 to July 2015. Before that, he worked at Shire Pharmaceuticals, serving as senior vice president—global franchise lead, Angioedema, from September 2012 to December 2013. Before the acquisition of Pervasis Therapeutics by Shire, Fred served as its president and chief executive officer since October 2008. Before Pervasis, Fred worked at Genzyme from 1999 to 2008, where he held various positions within the organization in Europe and in the U.S. culminating in his position as vice president and general manager of the Cardiovascular Business Unit. Previously, he held various sales and marketing roles in a medical device company in France. He is also a member of the Board of Directors for Dynacure SAS. He holds a B.S. in physics from Paris University, a M.S. from ESC La Rochelle and an MBA from INSEAD.